Latham & Watkins was honored with five awards at the LMG Life Sciences Awards EMEA 2023. Regarded as one of the industry’s leading programs, the prestigious annual awards recognize leading law firms and lawyers from across the region to celebrate their success in the life sciences industry.
The firm earned recognition in five key categories for the third consecutive year, including:
- Belgium Firm of the Year
- M&A Lawyer of the Year: Robbie McLaren, London partner and Global Vice Chair of Latham’s Healthcare & Life Sciences Industry Group
- Regulatory Advisor of the Year: Eveline Van Keymeulen, Brussels and Paris partner and Global Vice Chair of Latham’s Healthcare & Life Sciences Practice
- Impact Deal: Quidel’s US$6 billion acquisition of Ortho Clinical Diagnostics
- Impact Deal: Astorg’s acquisition of CordenPharma
LMG Life Sciences also shortlisted Latham in other categories, including Antitrust & Competition Firm of the Year, Regulatory Firm of the Year, France Firm of the Year, Italy Firm of the Year, and Germany Firm of the Year. Paris associate Jeanne Fabre was also commended as a finalist for the Regulatory Rising Star category.